JP2010509294A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010509294A5 JP2010509294A5 JP2009535751A JP2009535751A JP2010509294A5 JP 2010509294 A5 JP2010509294 A5 JP 2010509294A5 JP 2009535751 A JP2009535751 A JP 2009535751A JP 2009535751 A JP2009535751 A JP 2009535751A JP 2010509294 A5 JP2010509294 A5 JP 2010509294A5
- Authority
- JP
- Japan
- Prior art keywords
- injury
- group
- cells
- radiation damage
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000006378 damage Effects 0.000 claims 14
- 208000027418 Wounds and injury Diseases 0.000 claims 7
- 208000014674 injury Diseases 0.000 claims 7
- 230000005855 radiation Effects 0.000 claims 7
- 238000000338 in vitro Methods 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- -1 tri-substituted glycerol compound Chemical class 0.000 claims 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 238000011275 oncology therapy Methods 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000006699 (C1-C3) hydroxyalkyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 206010073306 Exposure to radiation Diseases 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical group [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 238000010322 bone marrow transplantation Methods 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000005865 ionizing radiation Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85817006P | 2006-11-10 | 2006-11-10 | |
| US60/858,170 | 2006-11-10 | ||
| PCT/EP2007/062181 WO2008055997A1 (en) | 2006-11-10 | 2007-11-09 | Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013159892A Division JP2013227341A (ja) | 2006-11-10 | 2013-07-31 | 放射線傷害治療のための三置換グリセロール化合物の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010509294A JP2010509294A (ja) | 2010-03-25 |
| JP2010509294A5 true JP2010509294A5 (https=) | 2011-01-06 |
| JP5512275B2 JP5512275B2 (ja) | 2014-06-04 |
Family
ID=38904569
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009535751A Active JP5512275B2 (ja) | 2006-11-10 | 2007-11-09 | 放射線傷害治療のための三置換グリセロール化合物の使用 |
| JP2013159892A Pending JP2013227341A (ja) | 2006-11-10 | 2013-07-31 | 放射線傷害治療のための三置換グリセロール化合物の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013159892A Pending JP2013227341A (ja) | 2006-11-10 | 2013-07-31 | 放射線傷害治療のための三置換グリセロール化合物の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100130449A1 (https=) |
| EP (1) | EP2089401B1 (https=) |
| JP (2) | JP5512275B2 (https=) |
| AU (1) | AU2007316589B2 (https=) |
| CA (1) | CA2668923C (https=) |
| DK (1) | DK2089401T3 (https=) |
| ES (1) | ES2391659T3 (https=) |
| RU (1) | RU2448973C2 (https=) |
| WO (1) | WO2008055997A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2448973C2 (ru) * | 2006-11-10 | 2012-04-27 | Альфаптозе ГмбХ | Применение соединений три-замещенного глицерина для лечения радиационных поражений |
| JP6411725B2 (ja) | 2013-10-31 | 2018-10-24 | 株式会社Ｎｔｔドコモ | 無線基地局、ユーザ端末および無線通信方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3827974A1 (de) * | 1988-08-18 | 1990-02-22 | Boehringer Mannheim Gmbh | Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen |
| DE3918082A1 (de) * | 1989-06-02 | 1991-01-24 | Max Planck Gesellschaft | Mittel gegen autoimmunerkrankungen |
| US5082846A (en) * | 1990-08-30 | 1992-01-21 | Sandoz Ltd. | Use of the R-(+)-isomer of 2-methoxy-3-octadecyloxy-propanol-(1)-phosphoric acid, monocholine ester in treating multiple sclerosis |
| DE19822509A1 (de) * | 1998-05-19 | 1999-11-25 | Medmark Pharma Gmbh | Edelfosin zur Behandlung von Hirntumoren |
| US20020102208A1 (en) * | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| SE517142C2 (sv) * | 2000-04-11 | 2002-04-23 | Delaval Holding Ab | Utfodringsanordning samt arrangemang och förfarande för automatisk mjölkutfodring |
| WO2005020935A2 (en) * | 2003-02-06 | 2005-03-10 | Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Method and composition of administering radioprotectants |
| RU2448973C2 (ru) * | 2006-11-10 | 2012-04-27 | Альфаптозе ГмбХ | Применение соединений три-замещенного глицерина для лечения радиационных поражений |
-
2007
- 2007-11-09 RU RU2009121836/04A patent/RU2448973C2/ru not_active IP Right Cessation
- 2007-11-09 AU AU2007316589A patent/AU2007316589B2/en not_active Ceased
- 2007-11-09 JP JP2009535751A patent/JP5512275B2/ja active Active
- 2007-11-09 EP EP07822469A patent/EP2089401B1/en not_active Not-in-force
- 2007-11-09 WO PCT/EP2007/062181 patent/WO2008055997A1/en not_active Ceased
- 2007-11-09 CA CA2668923A patent/CA2668923C/en not_active Expired - Fee Related
- 2007-11-09 DK DK07822469.8T patent/DK2089401T3/da active
- 2007-11-09 ES ES07822469T patent/ES2391659T3/es active Active
- 2007-11-09 US US12/514,329 patent/US20100130449A1/en not_active Abandoned
-
2013
- 2013-07-31 JP JP2013159892A patent/JP2013227341A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012530779A5 (https=) | ||
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| JP2020500862A5 (https=) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2009504763A5 (https=) | ||
| JP2012525393A5 (https=) | ||
| JP2006514689A5 (ja) | １−オキソ−２−（２，６−ジオキソピペリジン−３−イル）−４−メチルイソインドリンを含む脳腫瘍の治療及び管理のための医薬組成物 | |
| JP2013501731A5 (https=) | ||
| JP2017518334A5 (https=) | ||
| JP2010077141A5 (https=) | ||
| JP2018524298A5 (https=) | ||
| JP2013519632A5 (https=) | ||
| IL314360A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| RU2015107877A (ru) | Способы лечения болезни альцгеймера и фармацевтические композиции | |
| EA201290026A1 (ru) | Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid) | |
| JP2013507415A5 (https=) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| JP2011507896A5 (https=) | ||
| JP2014505017A5 (https=) | ||
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| JP2019516739A5 (https=) | ||
| JP2007520452A5 (https=) | ||
| RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| JP2016515550A5 (https=) | ||
| JP2010500284A5 (https=) |